Business Standard

Intas Pharmaceuticals Ltd - IPO

Issue Type

Book Building

Issue Size (₹ Cr.)

- cr

Price Range (₹)

0

Lot Size

-

Min Investment (₹)

-

Listing Exchange

MumbaiNSE

Open Date

-

Close Date

-

Listing Date

-

Intas Pharmaceuticals Ltd News

    Intas Pharmaceuticals Ltd IPO Details

    Public issue of upto [*] equity shares of face value of Rs. 10 each (Equity Shares) of Intas Pharmaceuticals Limited (The company or The Issuer) for cash at a price of Rs. [*] per equity share including a share premium of Rs. [*] per equity share, aggregating up to Rs. [*] crores (The Issue) comprising of a fresh issue of upto equity shares by the company aggregating upto Rs. 225.00 crores (The Fresh Issue) and an offer for sale of 11,621,100 equity shares by Mozart Limited aggregating upto Rs. [*] crores (The Selling Shareholder) (The Offer for sale). The issue shall constitute [*]% of the post-issue paid up capital and [*]% of the fully diluted post-issue paid up capital of the company. The Face value of the equity share is Rs. 10 each.

    Objective of issue

    Marketing authorization expenses. Setting up of research and development facility. General corporate purposes.

    Intas Pharmaceuticals Ltd Contact Details

    Intas Pharmaceuticals Ltd, C-13 Pannalal Silk, Mills Cmpd LBS Marg, Bhandup West, Mumbai - 400 078

    Phone - 91-022-25963838

    Fax - 91-022-25946969

    Email - manoj_nair@intaspharma.com

    Website - www.intaspharma.com